510(k) K243168

Alinity i Rubella IgG by Abbott Laboratories — Product Code LFX

K243168 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "Alinity i Rubella IgG". The FDA issued a decision of Substantially Equivalent on Jun 20, 2025. The device falls under product code LFX (Enzyme Linked Immunoabsorbent Assay, Rubella), a Class II device regulated under 21 CFR 866.3510. Abbott Laboratories has 889 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jun 20, 2025
Date Received
Sep 30, 2024
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Enzyme Linked Immunoabsorbent Assay, Rubella
Device Class
Class II
Regulation Number
866.3510
Review Panel
MI
Submission Type
510(k)

Need the full FDA record for Abbott Laboratories? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K243168. Report a data issue: hello@regdatalab.com.